Home/Pipeline/Diagnostic Biomarker Validation (Other Cancers)

Diagnostic Biomarker Validation (Other Cancers)

Other Cancers

Discovery/ValidationActive

Key Facts

Indication
Other Cancers
Phase
Discovery/Validation
Status
Active
Company

About Nordic-MUbio

Nordic-MUbio is a specialized antibody reagent company formed through the merger and acquisition of several legacy brands, including Nordic (founded 1964) and MUbio (spun out in 2000). It has established itself as a niche player in research-use-only antibodies, with a growing pipeline in diagnostic biomarker validation for cancers. The company pursues growth through targeted acquisitions, academic partnerships, and leveraging its core competencies in antibody validation and technical support.

View full company profile